{"slug":"diagnostics","tag":"diagnostics","variants":["diagnostics"],"description":"No description yet","count":5,"kinds":{"person":3,"trial":1,"technology":1},"related":[{"slug":"prostate","tag":"prostate","shared":2},{"slug":"uk","tag":"uk","shared":2},{"slug":"ctdna","tag":"ctdna","shared":1},{"slug":"genomics","tag":"genomics","shared":1},{"slug":"lymphoma","tag":"lymphoma","shared":1},{"slug":"mrd","tag":"mrd","shared":1},{"slug":"precision-oncology","tag":"precision oncology","shared":1}],"records":[{"id":"caroline-moore","kind":"person","name":"Caroline Moore","route":"/people/caroline-moore/","tldr":"The UCL urologist who has spent her career on the two questions that decide whether a man with prostate cancer is harmed by being diagnosed: who needs a biopsy, and who needs treating at all."},{"id":"promis","kind":"trial","name":"PROMIS","route":"/trials/promis/","status":"positive","tldr":"The British study that measured how bad the standard prostate biopsy really was, and how good a scan could be instead: the evidence that put MRI before the needle in the NHS."},{"id":"clonality-testing","kind":"technology","name":"Immunoglobulin and T-cell receptor clonality testing","route":"/technologies/clonality-testing/","tldr":"A test that asks whether a group of lymphocytes is one family descended from a single cell, or a crowd of unrelated ones. Cancer is one family. It is used when the appearance under the microscope is not enough to decide."},{"id":"michael-berger","kind":"person","name":"Michael F. Berger","route":"/people/michael-berger/","tldr":"Built MSK-IMPACT, the tumour sequencing test used on more than 100,000 patients and the first FDA-authorised hospital panel."},{"id":"viktor-adalsteinsson","kind":"person","name":"Viktor A. Adalsteinsson","route":"/people/viktor-adalsteinsson/","tldr":"Engineer who showed low-pass sequencing of blood can replace tumour biopsies and built ultra-sensitive MRD tests."}]}